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ABSTRACT 
A Genetic Dissection of Mitochondrial Respiratory Chain Biogenesis. (May 2014) 
 
Aaron Griffin, Sarah Theriault, Shrishiv Timbalia 
Department of Biochemistry and Biophysics 
Texas A&M University 
 
Research Advisor: Dr. Vishal Gohil 
Department of Biochemistry and Biophysics  
 
Mitochondria house the mitochondrial respiratory chain (MRC), the main site for cellular 
respiration and energy production. The MRC consists of five large protein complexes (I-V) in 
the inner mitochondrial membrane. Despite the fundamental role of the MRC in cellular energy 
generation and its involvement in several human diseases, we still do not know all the proteins 
required for its formation. To address this gap in our knowledge, we have developed an 
integrative approach based on clues from evolutionary history and protein localization to shortlist 
56 uncharacterized proteins that are physically localized to the mitochondria of yeast and 
humans. A recent study on mitochondrial disease patients identified potential pathogenic 
mutations in one of our prioritized candidate genes, C1orf31, suggesting its involvement in MRC 
biogenesis. Due to the lack of an assigned function to C1orf31, it was not possible to prove the 
pathogenicity of the patient mutations. Therefore, our study focused on determining the role of 
C1orf31 in MRC biogenesis. We identified a yeast, Saccharomyces cerevisiae, ortholog of 
C1orf31, named Coa6, by BLAST analysis, allowing us to use this genetically tractable model 
system to quickly decipher the protein’s function. Using coa6Δ yeast cells, we show that Coa6 is 
required for respiratory growth, cellular respiration, and MRC complex IV biogenesis. A 
sequence analysis of Coa6 identified a conserved, non-canonical, putative copper-binding motif, 
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suggesting its role in copper delivery to MRC complex IV, the only copper-containing MRC 
complex. Indeed, copper supplementation rescues the respiratory defect of coa6Δ yeast cells, 
while copper starvation exacerbates the respiratory growth phenotype. Furthermore, we show 
that conserved residues in the putative copper-binding motif, including the residues mutated in 
the human mitochondrial disease patient, are essential for Coa6 function, thus confirming the 
pathogenicity of the patient mutations. Based on these results, we hypothesize that Coa6 is a 
mitochondrial copper metallochaperone required for delivery of copper to MRC complex IV.  In 
support of this hypothesis, we show that the coa6Δ phenotype is exacerbated when the gene for 
another known copper metallochaperone, Sco2, is deleted, indicating that these two proteins 
have an overlapping function in delivering copper to MRC complex IV. 
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CHAPTER I 
 INTRODUCTION 
 
The mitochondrial respiratory chain (MRC) represents an evolutionarily conserved pathway of 
cellular energy generation. The MRC machinery consists of ~90 core subunits organized into 
five macromolecular complexes (complexes I-V) that are located in the mitochondrial inner 
membrane (Fig. 1). Of the 90 MRC subunits, only 13 are encoded by mtDNA. The rest are 
encoded by the nuclear genome, as are all of the other ~1000 protein components of the 
mitochondrion (1). The nuclear-encoded proteins are required for the replication and expression 
of mtDNA-encoded proteins, as well as the full assembly and maturation of the MRC (Fig. 1). 
Many of the proteins necessary for mtDNA maintenance, transcription, translation, and assembly 
of a fully operational MRC are currently unknown (1,2). Together, these proteins are commonly 
referred to as “MRC biogenesis” or “MRC assembly” factors. 
 
Mutations in genes required for building the MRC result in the most common inborn errors of 
metabolism with an estimated prevalence of 1 in 5,000 live births (3,4). Mitochondrial disease 
patients display a wide array of symptoms in vital organ systems – including heart defects, 
strokes, seizures, muscle weakness, deafness, and blindness – underlying the fundamental 
importance of MRC function to human health (3). 
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It is necessary to identify the full complement of MRC biogenesis factors in order to completely 
understand the fundamental process of cellular energy production and to address biomedical 
challenges stemming from mitochondrial disorders. Most high-throughput studies aimed at 
identifying MRC biogenesis factors have been performed using Saccharomyces cerevisiae yeast 
deletion strains. For example, combining computational and functional genomic approaches, 
Caudy et al. identified 100 new yeast mitochondrial proteins whose deficiency alters 
mitochondrial biogenesis (5). These studies in yeast indicate the presence of a large number of 
mitochondrial proteins dedicated to MRC biogenesis. Thus, in order to discover novel MRC 
biogenesis factors, it is useful to know the identity of all the mitochondrial proteins. The most 
 
 
Figure 1. The canonical pathway of MRC biogenesis. 
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updated and accurate list of human mitochondrial proteins, termed “MitoCarta,” consists of 
1,023 proteins (6). Approximately one quarter of the proteins listed in this inventory do not have 
an assigned function (Fig. 2A).  Because of their mitochondrial localization, these ‘orphan’ 
proteins provide an excellent starting point for discovering novel MRC biogenesis factors. 
 
 
Using these ‘orphan’ mitochondrial proteins as a starting point, we have designed an integrative 
genomics approach focused on identifying novel MRC biogenesis factors. Our approach is based 
on the premise that factors required for building a conserved pathway for mitochondrial ATP 
synthesis should also be highly conserved and localized to the mitochondria. Using the 
MitoCarta protein inventory as a starting point, we performed BLAST analyses to shortlist 
mitochondrial proteins of unknown function that are conserved between yeast and humans.  We 
found that, of the ~400 conserved mitochondrial proteins, 56 are completely uncharacterized 
(Fig. 2B). This shortlist of 56 evolutionarily conserved ‘orphan’ mitochondrial proteins should 
theoretically be highly enriched in novel MRC biogenesis factors.  To prioritize shortlisted 
 
 
Figure 2. An integrative genomics approach to identify novel MRC biogenesis factors. (A) Pie chart showing the 
proportion of human mitochondrial proteins with unknown function. (B) Venn diagram showing the 400 
evolutionarily conserved mitochondrial proteins between yeast and humans, 56 of which are uncharacterized.  
C1orf31/Coa6, the prioritized MRC biogenesis candidate, was selected from this subset. 
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proteins for further experimental analysis, we intersected our list with recently reported human 
mitochondrial disease genes identified through next-generation sequencing.  One of the 
shortlisted genes, C1orf31, now renamed COA6, was recently linked to a clinical case of 
neonatal hypertrophic cardiomyopathy in a mitochondrial disease patient (7), suggesting that it 
likely plays a critical role in MRC function and/or formation.  In the study, Calvo and colleagues 
used next-generation sequencing technologies to identify potential pathogenic mutations in 
C1orf31 of the mitochondrial disease patient (7).  However, due to the lack of an assigned 
function to C1orf31, it was not possible to determine if the mutations were responsible for the 
patient’s cardiomyopathy.  Due to its evolutionary conservation, its uncharacterized status, and 
its relevance in a clinical case of mitochondrial disease, we hypothesized that C1orf31/COA6 is 
a novel MRC biogenesis factor, and set out to investigate its role in MRC function and/or 
formation. 
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CHAPTER II 
MATERIALS AND METHODS 
 
Yeast strains, plasmids, and culture conditions 
 
Saccharomyces cerevisiae strains used in this study were obtained from Open Biosystems or 
independently created in the Gohil Laboratory as described below (Table 1). All strains were 
confirmed by PCR as well as by replica plating on dropout plates. For growth in liquid medium, 
yeast cells were pre-cultured in YPD (1% yeast extract, 2% peptone and 2% glucose) and then 
inoculated into medium containing either 2% glucose (YPD) or 3% glycerol + 1% ethanol 
(YPGE) and grown to early stationary phase. Solid YPD and YPGE media were prepared by the 
addition of 2% agar. For metal supplementation experiments, growth medium was supplemented 
with 5 µM divalent chloride salts of Cu, Co, Mg, or Zn. A Gateway cloning vector pAG423-
GPD-ccdB-HA (Addgene) was used to perform site-directed mutagenesis (Agilent Technologies 
QuikChange Lightning) for generating all the point mutants. All constructs were confirmed by 
DNA sequencing. Yeast cells transformed with the pAG423GPD-ccdB-HA vector were pre-
cultured in 2% glucose-containing synthetic media lacking histidine before plating on YPGE.  
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Table 1 
Yeast strains used in this study 
Strain Genotype Source 
coa6∆ 
 
Mat α, his301, leu200, lys200, ura300, coa6∆::clonNAT 
 
This study 
cox17∆ 
 
Mat a, his301, leu200, met1500, ura300, cox17∆::hygro This study 
cox11∆ Mat a, his301, leu200, met1500, ura300, cox11∆::KanMX4 
 
Open 
Biosystems 
cox12∆ Mat a, his301, leu200, met1500, ura300, cox12∆::KanMX4 
 
Open 
Biosystems 
cox19∆ Mat a, his301, leu200, met1500, ura300, cox19∆::KanMX4 
 
Open 
Biosystems 
cox23∆ Mat a, his301, leu200, met1500, ura300, cox23∆::KanMX4 
 
Open 
Biosystems 
cmc1∆ Mat a, his301, leu200, met1500, ura300, cmc1∆::KanMX4 
 
Open 
Biosystems 
cmc3∆ Mat a, his301, leu200, met1500, ura300, cmc3∆::KanMX4 
 
Open 
Biosystems 
cmc4∆ Mat a, his301, leu200, met1500, ura300, cmc4∆::KanMX4 
 
Open 
Biosystems 
sco1∆ Mat a, his301, leu200, met1500, ura300, sco1∆::KanMX4 
 
Open 
Biosystems 
sco2∆ Mat a, his301, leu200, met1500, ura300, sco2∆::KanMX4 
 
Open 
Biosystems 
pic2∆ Mat a, his301, leu200, met1500, ura300, pic2∆::KanMX4 
 
Open 
Biosystems 
STY1 
(cox17∆coa6∆) 
Mat a, his301, leu200, ura300, lys200, met1500, cox17∆::hygro, 
coa6∆::clonNAT 
This study 
STY2 
(cox11∆coa6∆) 
Mat a, his301, leu200, ura300, cox11∆::KanMX4, coa6∆::clonNAT This study 
STY3 
(cox12∆coa6∆) 
Mat a, his301, leu200, ura300, lys200, met1500, cox12∆::KanMX4, 
coa6∆::clonNAT 
This study 
STY4 
(cox19∆coa6∆) 
Mat a, his301, leu200, ura300, lys200, cox19∆::KanMX4, 
coa6∆::clonNAT 
This study 
STY5 
(cox23∆coa6∆) 
Mat a, his301,leu200, ura300, cox23∆::KanMX4, coa6∆::clonNAT This study 
STY6 
(cmc1∆coa6∆) 
Mat a, his301, leu200, ura300, lys200, cmc1∆::KanMX4, 
coa6∆::clonNAT 
This study 
STY7 
(cmc3∆coa6∆) 
Mat α, his301, leu200, ura300, cmc3∆::KanMX4, coa6∆::clonNAT This study 
STY8 
(cmc4∆coa6∆) 
Mat α, his301, leu200, ura300, lys200, cmc4∆::KanMX4, 
coa6∆::clonNAT 
This study 
STY9 
(sco1∆coa6∆) 
Mat a, his301, leu200, ura300, met1500, sco1∆::KanMX4, 
coa6∆::clonNAT 
This study 
STY10 
(sco2∆coa6∆) 
Mat a, his301, leu200, ura300, lys200, sco2∆::KanMX4, 
coa6∆::clonNAT 
This study 
STY11 
(pic2∆coa6∆) 
Mat a, his301, leu200, ura300, met1500, pic2∆::KanMX4, 
coa6∆::clonNAT 
This study 
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Primer sequences for knockout cassette PCR amplification were determined using 45 bp 
upstream and 45 bp downstream of the open reading frame of the gene of interest, as well as 15 
bp sequence homologous to the drug resistant cassettes (Table 2). The cassettes used were 
hphMX4 (resistant to hygromycin) and natMX4 (resistant to clonNAT). Plasmids were extracted 
from E. coli using the Qiagen plasmid prep kit (Cat. #27104) and the DNA concentration was 
measured using a nanodrop (Thermo Scientific Nanodrop 1000).  PCR was performed in order to 
amplify the cassettes from the plasmids by using the plasmid template, 10x polymerase buffer, 
the forward primer, the reverse primer, the dNTP mix, the Taq polymerase, and water. DMSO 
was added when amplifying the natMX4 cassette due to its high GC content. After PCR, agarose 
gel electrophoresis was performed in order to obtain the DNA of interest. This band of DNA was 
cut out using the Qiagen gel extraction kit (Cat. #28704) and the DNA concentrations were 
recorded using a nanodrop (Thermo Scientific Nanodrop 1000). The cassette PCR products were 
transformed into S. cerevisiae using the One Step Transformation protocol and spread onto YPD 
media plates. The transformation lawns were then replica plated onto media containing 
hygromycin and clonNAT. The colonies that grew on these plates were then genotyped (Table 1) 
and checked for accurate gene deletion by PCR (Table 3). 
 
Table 2 
Primer sequences for knockout cassette PCR amplification 
Primer Primer Sequence (5' - 3') 
COA6 
S1 
  ATACACGAATATACAGAAAGGAATAGTAGTAATATAGCGATGCGTACGCTGCAGGTCGAC 
COA6 
S2 
ATATATATGTTAATATGAGCCAATAACTCACTAAAAACTCAATCGATGAATTCGAGCTCG 
COX17 
S1 
  GTGTACACAATCAGATAACTACACAATCAATTATACCCAATGCGTACGCTGCAGGTCGAC 
COX17 
S2 
 ATATACAAGAAATGGTTGTCGGCAGACTGTCAGTAAGACTAATCGATGAATTCGAGCTCG 
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Yeast growth measurements 
 
Growth curves were carried out in glucose containing fermentable media (YPD) and glycerol-
ethanol containing non-fermentable media (YPGE). Yeast cells were precultured in 2 ml of YPD 
media in snap cap tubes for 16 to 20 hours at 30°C and 250 RPM. The next day, the optical 
density of the preculture was taken using a spectrophotometer (Beckman Coulter DU 730).  The 
preculture was diluted to an initial OD of 0.1 in 7.5 ml YPGE or YPD in 50 ml Falcon tubes; the 
tubes were then placed in an incubator-shaker at 30°C and 250 RPM. At the specified time 
points, the optical density of the media was measured by aliquoting 500 µl into cuvettes (VWR 
97000-586). If the optical density was beyond the linear range of the instrument (0.05 to 0.800), 
the samples were diluted. 
 
Spotting was utilized as a method of qualitatively evaluating growth under different conditions. 
Cell number of overnight precultures of yeast strains were counted by hemocytometer and were 
serially diluted at 10
4
, 10
3
, 10
2
, and 10
1
 cells per 3 µl. Dilutions were spotted onto plates 
containing different media as indicated and incubated at 30°C or 37°C for 2-5 days. 
 
Streaking was utilized as an additional method of qualitatively evaluating growth under different 
conditions. Single colonies of yeast strains were isolated and streaked onto media plates, then 
incubated at 30°C or 37°C for 2-5 days. 
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Yeast oxygen consumption and mitochondrial isolation 
 
BY4741 WT and coa6Δ cells were grown in YPD media to late log phase and then washed, 
counted, and resuspended in the assay medium (0.176% yeast nitrogen base, 0.5% NH4SO4 and 
2% ethanol) before seeding in XF24-well microplates (Seahorse Bioscience) at 5 x 10
5
 
cells/well. After seeding, cells were centrifuged at 100 x g for 2 min and incubated at 30°C for 
30 min in the assay medium prior to measurements. The cellular oxygen consumption rate 
(OCR) was measured using an XF24 extracellular flux analyzer (Seahorse Biosciences) at 30°C. 
Mitochondria were isolated from yeast cells grown to late log phase in YPD by the previously 
described method (8) and protein concentrations were determined by the BCA assay (Thermo 
Scientific). Mitochondrial samples were stored at -80°C before performing any protein analysis. 
 
SDS-PAGE and Western blotting  
 
Denaturing sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed to separate denatured MRC protein complexes. SDS-PAGE was performed on 
mitochondrial samples solubilized in RIPA lysis buffer (150 mM NaCl, 1 mM EDTA, 50 mM 
Tris HCl pH 7.4, 1% NP-40, 0.5% sodium deoxycholate and 0.1% SDS) supplemented with 
protease inhibitor cocktail (Roche Diagnostic). Western blot was performed using a Trans-Blot 
transfer cell (Bio-Rad). Membranes were blocked in 5% fatty acid free BSA dissolved in Tris-
buffered saline with 0.1% Tween 20 (TBST-BSA) and probed with antibodies as indicated. The 
separated proteins were blotted onto a polyvinylidene difluoride membrane and blocked for 1h at 
room temperature in TBST-BSA. Membranes were incubated with primary antibody in TBST-
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BSA overnight at 4°C. The primary antibodies for yeast were used at the following dilutions: 
Cox2, 1:1,000 (Abcam 110271); Cox3, 1:1,000 (Abcam 110259); Sdh2, 1:5,000 (from Dr. 
Dennis Winge); Rip1, 1:50,000 (from Dr. Vincenzo Zara); Atp2, 1:40,000 (from Dr. Sharon 
Ackerman); Porin, 1:1,000 (Abcam 110326). Membranes were developed using Western 
Lightning Plus-ECL (PerkinElmer). 
 
Sporulation, tetrad dissection, and genotyping 
 
Diploid strains were grown in an overnight culture of YPD at 30°C while shaking at 250 rpm.  
The culture was then diluted by a factor of 1:50 and left to grow for 4 hours while shaking at 
30°C. The culture was spun down, washed with sterile water, and resuspended in 2mL of 
sporulation media, composed of potassium acetate, yeast extract, dextrose, uracil, adenine, 
leucine, lysine, methionine, histidine, tryptophan, threonine, and arginine. This new culture was 
then stored at room temperature with shaking for one day and incubated at 30°C with shaking for 
4-5 days, or until a sufficient number of tetrads was observed using a tetrad dissection 
microscope.  
 
Tetrad dissection was performed to obtain haploid spores from tetrads formed during 
sporulation.  The enzyme lyticase (Cat. #SLBD1179V from Sigma) at 0.5 mg/mL in 1 M sorbitol 
solution was used to digest the cell walls of tetrads, allowing for easier dissection.  Following the 
addition of lyticase, a wide-bore pipette tip was used to deposit 30 μL of culture down the center 
of a YPD plate. Using a Nikon Eclipse Ci microscope customized with tetrad dissecting arm and 
stage, tetrads were located, and spores were isolated and redistributed at separate coordinates 
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along a horizontal line using a fine glass needle. This process was repeated for ~18 different 
tetrads and the plate was then stored for 2-3 days at 30°C for spores to grow. 
 
After the tetrad dissection, each spore was isolated and transferred to a fresh YPD plate. This 
master plate was incubated at 30°C and subsequently used to replica plate onto media containing 
selective markers for genotyping. Synthetic media plates used in this process include CSM 
(complete synthetic media with Glucose), CSHis (CSM that lacks the amino acid histidine), 
CSLys (CSM that lacks the amino acid lysine), CSLeu (CSM that lacks the amino acid leucine), 
CSUra (CSM that lacks the amino acid uracil), and CSMet (CSM that lacks the amino acid 
methionine). YPD plates with the antibiotic hygromycin, CSM plates with the antibiotic 
clonNAT, and YPD plates with the antibiotic geneticin were used to determine which haploid 
spores received which deletion cassette.  Finally, CSM lacking all amino acids was used to 
determine the mating type of each haploid spore.  Double knockout strains were confirmed by 
PCR (Table 3). 
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Table 3 
PCR confirmation of yeast knockout strains 
Yeast Strain Primers Observed Band Size 
Expected Band Size 
(bp) 
WT Coa6A/Coa6D ~910 898 
WT Cox17A/Cox17D ~1000 1006 
STY1 (coa6∆ cox17∆) 
Cox17A/Cox17D ~2300 2300 
Coa6A/Coa6D ~1800 1800 
WT Cox11A/Cox11D ~1400 1408 
STY2 (coa6∆ cox11∆) 
Cox11A/Cox11D ~2000 2089 
Coa6A/Coa6D ~1800 1800 
WT Cox12A/Cox12D ~750 828 
STY3 (coa6∆ cox12∆) 
Cox12A/Cox12D ~2000 2160 
Coa6A/Coa6D ~1800 1800 
WT Cox19A/Cox19D ~900 900 
STY4 (coa6∆ cox19∆) 
Cox19A/Cox19D ~2100 2215 
Coa6A/Coa6D ~1800 1800 
WT Cox23A/Cox23D ~1000 1036 
STY5 (coa6∆ cox23∆) 
Cox23A/Cox23D ~2000 2164 
Coa6A/Coa6D ~1800 1800 
WT Cmc1A/Cmc1D ~950 1000 
STY6 (coa6∆ cmc1∆) 
Cmc1A/Cmc1D ~2000 2272 
Coa6A/Coa6D ~1800 1800 
WT Cmc3A/Cmc3D ~950 960 
STY7 (coa6∆ cmc3∆) 
Cmc3A/Cmc3D ~2000 2091 
Coa6A/Coa6D ~1800 1800 
WT Cmc4A/Cmc4D ~800 800 
STY8 (coa6∆ cmc4∆) 
Cmc4A/Cmc4D ~2000 2158 
Coa6A/Coa6D ~1800 1800 
WT Sco1A/Sco1D ~1450 1542 
STY9 (coa6∆ sco1∆) 
Sco1A/Sco1D ~2000 2105 
Coa6A/Coa6D ~1800 1800 
WT Sco2A/Sco2D ~1550 1661 
STY10 (coa6∆ sco2∆) 
Sco2A/Sco2D ~2100 2238 
Coa6A/Coa6D ~1800 1800 
WT Pic2A/Pic2D ~1100 1185 
STY11 (coa6∆ pic2∆) 
Pic2A/Pic2D ~1900 1866 
Coa6A/Coa6D ~1800 1800 
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High-throughput phenotypic analysis of yeast strains 
 
WT and selected mutant strains were precultured in 2 ml of YPD media in snap cap tubes for 16 
to 20 hours at 30°C and 250 RPM. Cell number of overnight precultured yeast strains were 
counted by hemocytometer and were serially diluted at 10
4
, 10
3
, 10
2
, and 10
1
 cells per 1.5 µl in 
1.7 mL eppendorf tubes. 200 µl of each diluted yeast strain was transferred into the 
corresponding well of a 96 deep-well plate (E&K Scientific EK-36261). The remaining seventy-
two wells received 180 µl of autoclaved water, and a multichannel pipette (Eppendorf 
3122000043) was used to make 1:10 serial dilutions.  The 96 pin deep-well replicator (V&P 
Scientific 407AM) was cleaned prior to stamping with cleaning solution (V&P Scientific 110), 
distilled water, and ethanol, followed by flaming.  Nunc OmniTray rectangular solid media 
plates (Thermo Scientific 242811) were obtained. A library copier (V&P Scientific 381A) and as 
a colony copier (V&P Scientific 380) were used to ensure even replicator insertion into the 96 
deep well plate and application to the media, respectively.  Following application of yeast to 
media, the plates were incubated at 30°C or 37°C for three to five days.    
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CHAPTER III 
RESULTS 
 
Coa6 is required for respiration in yeast Saccharomyces cerevisiae  
 
Because of the ease of performing biochemical and functional genomic experiments, we utilized 
S. cerevisiae as a model system to uncover the role of Coa6 in mitochondrial energy metabolism. 
Yeast with deletion in MRC genes are viable because in the presence of glucose yeast 
preferentially generate cellular energy through fermentation, bypassing the need for a functional 
MRC. This property of yeast makes it an attractive model system to use when studying MRC 
biogenesis. A defect in the MRC can be revealed when yeast are forced to generate cellular 
energy using the mitochondria by growing them in the presence of a non-fermentable carbon 
source, such as glycerol or ethanol. We began our experiments by extensively characterizing the 
growth of coa6Δ yeast cells in different carbon sources and at varying temperatures. Yeast prefer 
to grow at 30°C, so growing the yeast at a higher temperature, such as 37°C, can add stress that 
may expose a phenotype too subtle to observe at 30°C. The growth of coa6Δ cells in liquid 
glucose-containing fermentable medium (YPD), as measured by spectrophotometry, is 
comparable to wildtype (WT) up to the early stationary phase, approximately twelve hours (Fig. 
3A). At this point, the yeast have metabolized all available glucose into ethanol via fermentation 
pathways, and continued growth can only be achieved by shifting energy metabolism to process 
ethanol using the MRC. The coa6Δ cells have reduced growth in the stationary phase in YPD 
media compared to WT, indicating their inability to make this metabolic shift due to a defect in 
mitochondrial energy metabolism (Fig. 3A).  Furthermore, in liquid glycerol/ethanol-containing, 
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non-fermentable medium (YPGE), coa6Δ demonstrates impaired growth and an extended lag 
phase compared to WT, indicating that the yeast possess a defective MRC (Fig. 3B). As 
expected, the growth of coa6Δ in solid YPD medium was comparable to WT, but the growth in 
solid YPGE was reduced, with the effect being more severe at 37°C (Fig. 3C). The growth defect 
of coa6Δ cells in non-fermentable media suggested respiratory deficiency.  To directly assess 
respiration, we measured oxygen consumption in WT and coa6Δ cells and observed a 
statistically significant 50% decrease in the oxygen consumption rate (OCR) of coa6Δ cells 
compared with WT cells (Fig. 3D). 
 
 
Figure 3. Yeast coa6Δ cells exhibit reduced respiration. (A) WT and coa6Δ cells were precultured in YPD and 
inoculated in fresh YPD liquid media at 30°C with a starting A600 of 0.1. Absorbance was measured at the 
indicated times at 600 nm. Data are representative of at least three independent measurements. (B) WT and 
coa6Δ cells were precultured in YPD and inoculated in fresh YPGE liquid media at 30°C with a starting A600 of 
0.1. Absorbance was measured at the indicated times at 600 nm. Data are representative of at least three 
independent measurements. (C) Serial dilutions of WT and coa6Δ cells were spotted on YPD and YPGE plates 
at 30°C and 37°C. Pictures were taken after 2–5 days of spotting. Data are representative of three independent 
experiments. (D) WT and coa6Δ cells were grown overnight in YPD at 30°C. After 18 h of growth, cells were 
harvested, washed, counted and resuspended in ethanol-containing respiratory medium. Basal oxygen 
consumption rate (OCR) was measured on half a million cells using an extracellular flux analyzer. Error bars 
represent mean + SD (n = 10); ∗ denotes statistically significant differences, P < 0.001, t-test. 
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Coa6 is required for MRC complex IV assembly 
 
In order to unravel the biochemical basis of the reduced respiration of coa6Δ cells, we performed 
a Western blot analysis of MRC proteins from WT and coa6Δ cells under denaturing conditions 
(SDS-PAGE). We observed a specific reduction in MRC Complex IV, also known as 
Cytochrome c Oxidase (CcO), by probing for CcO subunits Cox2 and Cox3 (Fig. 4).  There was 
no alteration in the subunits of any other MRC complexes. Taken together, these results 
demonstrate that Coa6 is required for CcO assembly. 
 
Coa6 contains an evolutionarily conserved Cx9C-Cx10C motif 
 
Having implicated Coa6 in the biological process of CcO biogenesis, we sought to further 
characterize Coa6 and determine its molecular function. For this, we analyzed the amino acid 
sequence alignment of Coa6 across five different model systems: yeast (Saccharomyces 
 
Figure 4. Yeast coa6Δ cells exhibit diminished 
CcO assembly. Mitochondria were isolated from 
WT and coa6Δ cells grown to early stationary 
phase in YPD medium. Mitochondrial protein 
was extracted and analyzed by SDS-
PAGE/Western blot. Subunit-specific antibodies 
were used to detect MRC complexes II–V. Porin 
was used as loading control. 
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cerevisiae), fly (Drosophila melanogaster), fish (Danio rerio), rat (Rattus norvegicus), and 
humans (Homo sapiens).  Our analysis showed that Coa6 contains a non-canonical conserved 
Cx9C-Cx10C motif (Fig. 5).  The importance of this motif was underscored not only due to its 
evolutionary conservation, but also due to the fact that the mutations in the mitochondrial disease 
patient were identified in this motif (7) (Fig. 5). This evolutionarily conserved Cx9C-Cx10C motif 
is highly similar to the twin Cx9C motif found in a group of mitochondrial proteins which, like 
Coa6, are known to localize to the mitochondrial intermembrane space (IMS) (10), and have 
been studied for their role in MRC biogenesis, specifically through the delivery of copper (Cu) 
ions to CcO (9,11). 
 
 
Exogenous copper supplementation rescues the respiratory growth defect of coa6Δ cells 
 
The identification of a conserved, non-canonical Cx9C-Cx10C motif in Coa6 suggested that it acts 
similarly to the previously identified Cx9C proteins and plays a role in the delivery of Cu to CcO. 
The deletion of Cox17, a well characterized twin Cx9C protein and a known Cu 
metallochaperone, results in decreased CcO levels and a loss of respiratory growth in yeast (12).  
Figure 5. COA6 contains an evolutionarily conserved Cx9C-Cx10C motif. Sequence alignment of the conserved 
region of the human COA6 protein with its orthologs in yeast (Saccharomyces cerevisiae), fly (Drosophila 
melanogaster), fish (Danio rerio), and rat (Rattus norvegicus). The sequence alignment was performed using 
ClustalW. Horizontal lines above Cx9C and Cx10C residues show the conserved motif. Arrows indicate amino 
acid residues (tryptophan 59 and glutamic acid 87) that were mutated in the mitochondrial disease patient (7). 
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However, growth in these cells can be restored by the addition of exogenous copper salts (12).  
We asked whether exogenous Cu supplementation could rescue the growth defect of coa6Δ cells. 
Remarkably, Cu supplementation completely restored respiratory growth in coa6Δ cells in both 
solid and liquid media (Fig. 6A & B). Notably, the rescue was specific to Cu, as supplementation 
with the other bivalent metals, including cobalt, magnesium, and zinc, failed to rescue the 
respiratory growth defect (Fig. 6A & B).  The depletion of Cu in synthetic media with an 
extracellular copper-specific chelator, bathocuproinedisulfonic acid, completely inhibited the 
growth of coa6Δ cells on non-fermentable medium, even at 30°C (Fig. 6C). These results 
implicate Coa6 in mitochondrial Cu metabolism and transport to CcO. 
 
 
  
 
Figure 6. Cu supplementation rescues the respiratory growth defect of coa6Δ. (A) Serially diluted WT and 
coa6Δ cells were spotted on YPGE plates in the presence and absence of 5 µM Cu, Co, Mg and Zn bivalent salts 
at 30°C and 37°C and allowed to grow for 4 –5 days before imaging. (B) Growth of WT and coa6Δ cells in 
YPGE liquid media in the presence of 5 µM Cu, Co, Mg and Zn bivalent salts at 30°C. (C) Serial dilutions of 
WT and coa6Δ strains grown in synthetic medium with a non-fermentable carbon source (2% glycerol; CSG) 
with or without 20 µM bathocuproinedisulfonic acid (BCS). The pictures were taken 5 days after seeding. 
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Point mutations in the conserved Cx9C-Cx10C motif disrupt Coa6 function 
 
Following the discovery that Cu supplementation restores the growth of coa6Δ cells, we sought 
to interrogate the importance of the Cx9C-Cx10C for the function of Coa6.  The mutations in the 
mitochondrial disease patient presented in the Cx9C-Cx10C motif as a missense mutation in the 
conserved tryptophan residue (p.W59C) and a nonsense mutation in the conserved glutamic acid 
residue (p.E87X) (7) (Fig. 7A). In order to test the requirement of the conserved cysteines and 
the effect of the patient mutations on Coa6 function, we cloned yeast COA6 into the Gateway 
expression vector pAG423GPD-ccdB-HA and performed site-directed mutagenesis to replace 
each of the four cysteines of the Cx9C-Cx10C motif with alanines. Cysteines contain a thiol 
functional group, which are known to coordinate Cu ions.  Replacing the cysteines with alanines, 
which do not contain thiols, represent a sufficient alteration in the function of the amino acid to 
assess the requirement of the cysteines for protein function.  We also replaced the conserved 
tryptophan with a cysteine (p.W26C) to mimic the first patient mutation (p.W59C). The second 
patient mutation (p.E87X) is a nonsense mutation that results in a truncated protein devoid of the 
fourth conserved cysteine, which is mimicked by the construct with a Coa6 (p.C68A) mutation. 
While WT COA6 rescued the respiratory growth defect of coa6Δ cells, none of the point 
mutations in conserved residues, including the patient mutation, could rescue the respiratory 
growth phenotype, suggesting their critical requirement for Coa6 function (Fig. 7B). Notably, 
growth was most deficient in the yeast strain whose constructs corresponded to the nonsense 
patient mutation. These results confirm the importance of the Cx9C-Cx10C motif for protein 
function, and suggest that the mutations reported in the described mitochondrial disease patient 
likely played a causal role in the disease pathogenesis. 
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COA6 is synthetic sick with SCO2 and COX12  
 
After demonstrating the necessity of the Cx9C-Cx10C motif for the function of Coa6 and 
implicating the protein in the delivery of Cu to CcO, we sought to further analyze the genetic 
interaction between Coa6 and assembly factors also hypothesized to play a role in the delivery of 
Cu to CcO.  We constructed a coa6Δ::clonNAT strain in MATα background and mated it with 
 
Figure 7. Conserved residues in the Cx9C-Cx10C motif are essential for protein 
function. (A) Schematic representation of the Cx9C-Cx10C motif of human COA6 and 
yeast Coa6 proteins showing the location of cysteine and tryptophan residues (arrows) 
targeted for site-directed mutagenesis. (B) WT and coa6Δ cells transformed with 
empty vector (EV), COA6, or one of its mutant forms were streaked onto YPGE plates 
and incubated at 30°C or 37°C for 5 days before imaging. 
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MATa KANMX4 knockout strains for Cox11, Cox12, Cox19, Cox23, Cmc1, Cmc3, Cmc4, 
Sco1, Sco2, and Pic2, as well as a MATa hygro knockout strain for Cox17.  The genotypes were 
confirmed by replica plating (Table 1), and successful chromosomal gene deletions were 
confirmed by PCR (Table 3).  Each of these proteins either contains a twin Cx9C motif (9), a 
Cx9C-Cx10C motif (13), or has been implicated in mitochondrial Cu metabolism (9,14). The 
resulting heterozygous diploids were sporulated, and meiotic tetrad analysis was carried out.  
Three independent tetrad counts were performed for each double knockout construct, and the 
relative frequency of tetrad formation indicated the genetic viability of the double knockouts 
(Fig. 8).  Notably, cox12Δcoa6Δ, cox17Δcoa6Δ, sco1Δcoa6Δ, sco2Δcoa6Δ, and pic2Δcoa6Δ 
showed a significant decrease in tetrad formation, indicating that these double knockouts 
possessed a much lower fitness than other double knockouts or WT (Fig. 8). 
 
 
A high-throughput growth experiment was designed in which four serial dilutions of WT, coa6Δ, 
cox11Δ, cox12Δ, cox17Δ, cox19Δ, cox23Δ, cmc1Δ, cmc3Δ, cmc4Δ, sco1Δ, sco2Δ, and pic2Δ 
 
Figure 8. The fitness of the double knockouts demonstrates genetic interaction between COA6 and CcO 
assembly factors. Haploid single knockouts of opposite mating types were mated, precultured overnight in YPD, 
and sporulated. The number of tetrads per 200 cells on day 5 was quantified by hemocytometer.  Data reflects 
three independent trials. 
 24 
 
strains, as well as the eleven double knockout strains (Table 1), were made in a 96 deep well 
plate. The yeast were stamped onto synthetic media containing glucose, galactose, or glycerol, 
and grown at 30°C or 37°C for three to five days.  Galactose was chosen as a respiro-
fermentative media since galactose does not activate the carbon catabolite repression pathways 
that prevent mitochondrial biogenesis when yeast are grown in the presence of glucose (15).  The 
layout of the stamping plate and an example of a synthetic glucose stamping experiment are 
displayed (Fig 9A). In order to identify genetic interactions between COA6 and other CcO 
assembly factors implicated in mitochondrial Cu metabolism, we performed the high-throughput 
phenotypic analysis by searching for double knockouts whose growth defect was more severe 
than the growth defect of the least proliferating parent strain. Growth was measured by counting 
the number of serial dilutions which had grown on the solid media plate.  All strains grew well in 
glucose containing media at 30°C, indicating that the deletion of COA6 in addition to genes for 
other CcO assembly factors was not lethal in fermentable conditions (Fig. 9B).  In galactose 
containing synthetic media, COA6 demonstrated synthetic sick interaction with both COX12 and 
COX23, and in glycerol containing synthetic media, COA6 demonstrated synthetic sick 
interaction with SCO2, CMC1, and CMC3 (Fig. 9B).  An additional phenotypic analysis was 
carried out to score the growth of the double knockouts of COA6 with COX12 and SCO2.  A 
spotting analysis on synthetic galactose and glycerol media with and without Cu supplementation 
showed that cox12Δcoa6Δ and sco2Δcoa6Δ have severe growth defects beyond the growth 
defects of coa6Δ, sco2Δ, or cox12Δ (Fig. 9C & D).  Additionally, neither double knockout’s 
growth was rescued by Cu supplementation (Fig. 9C & D), suggesting that Sco2 and Cox12 act 
downstream of or parallel to Coa6 in the Cu delivery pathway to CcO. 
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Figure 9. High-throughput phenotypic analysis of double knockouts reveals synthetic sick phenotypes. (A) 
Schematic indicating the position and concentration of yeast strain dilutions on rectangular media next to a 
synthetic glucose example. (B) Growth analysis of double knockouts relative to WT and parent strains on 
glucose, galactose, and glycerol containing synthetic media at 30°C or 37°C after three to five days. (C) Spotting 
analysis demonstrates cox12Δcoa6Δ and sco2Δcoa6Δ possess a respiratory growth defect on galactose and 
glycerol media, respectively, and are not rescued by exogenous Cu supplementation. 
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CHAPTER IV 
DISCUSSION 
 
Despite the fundamental importance of the MRC in cellular energy production and human health, 
many of the factors required for its biogenesis are still unknown.  To address this gap in our 
knowledge of mitochondrial biogenesis, we used an integrative approach based on clues from 
evolutionary history, protein localization studies, and human genetics to identify novel putative 
MRC biogenesis factors. Mutations in one of our prioritized candidates, C1orf31/COA6, were 
identified in a mitochondrial disease patient (7), suggesting its critical importance for MRC 
function and/or formation. Detailed experimental analysis using a yeast knockout model of 
COA6 deficiency showed its critical requirement for mitochondrial respiration and CcO 
biogenesis.  The specific requirement of Coa6 for CcO biogenesis, its intramitochondrial 
localization (10), and the presence of an evolutionarily conserved Cx9C-Cx10C motif suggested a 
role in mitochondrial Cu metabolism (9,11).  In support of this, we show that exogenous Cu 
supplementation completely rescues the respiratory defect in yeast coa6Δ cells (Fig. 6), and the 
conserved residues within the putative, non-canonical Cu binding Cx9C-Cx10C motif are 
essential for protein function (Fig. 7). Furthermore, we identified synthetic sick interaction of 
COA6 with known Cu metallochaperones (Fig. 9). Taken together, our study shows that Coa6 is 
an evolutionarily conserved MRC biogenesis factor that facilitates CcO assembly by regulating 
mitochondrial Cu metabolism. 
 
In our search for novel MRC biogenesis factors, we chose to focus on COA6 because three 
independent lines of evidence linked it to MRC function.  First, it is an evolutionarily conserved 
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protein that localizes to yeast and mammalian mitochondria (10,6).  Second, previous genomic 
and proteomic studies in yeast have shown that Coa6 plays a role in CcO assembly and interacts 
with known MRC components (16,10).  Third, potential pathogenic mutations were reported in 
the conserved residues of COA6 in a mitochondrial disease patient (7).  Utilizing a knockout 
model in the yeast S. cerevisiae, we showed that Coa6 is essential for the maintenance of steady-
state levels of CcO (Fig. 4) and its deficiency results in reduced respiration (Fig. 3D).  The 
patient mutations were present within conserved residues of the evolutionarily conserved Cx9C-
Cx10C motif, suggesting their essential function (7) (Fig. 5). We generated point mutations in the 
yeast Coa6 protein that were synonymous to compound heterozygous mutations reported in the 
human patient, and showed that mutant proteins failed to rescue the respiratory deficient growth 
of coa6Δ cells (Fig. 6B), thus establishing the pathogenicity of the patient mutations, as well as 
confirming the functional requirement of the Cx9C-Cx10C motif.  
 
The evolutionarily conserved, non-canonical Cx9C-Cx10C motif of Coa6 is similar to the twin 
Cx9C motif found in a subset of mitochondrial IMS involved in Cu delivery to CcO (9). The 
rescue of respiratory growth defect of yeast coa6Δ cells with exogenous Cu supplementation 
suggests a role for Coa6 in the Cu-delivery pathway to CcO. Notably, genetic mutations in three 
IMS proteins, the mitochondrial Cu metallochaperones, Sco1 and Sco2, and a twin Cx9C protein 
C2orf64/COA5, have been previously reported in mitochondrial disease patients with 
pronounced CcO deficiency and distinct, early-onset fatal clinical phenotypes (17-19). Patients 
with SCO1 mutations suffer from neonatal hepatic failure and ketoacidotic coma, whereas SCO2 
and COA5 mutations are associated with fatal neonatal cardiomyopathy. The clinical symptoms 
of the COA6 mutations are thus similar to SCO2 and COA5 patient mutations, suggesting that 
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these proteins partake in a common biochemical process. This idea is further strengthened by the 
respiratory genetic synthetic sick interaction of COA6 and SCO2 (Fig. 9B & C).  Interestingly, 
Cu supplementation has been shown to rescue CcO activity in patient-derived SCO2 mutant 
cells, as well as improve the clinical symptoms of patients suffering from aberrant mitochondrial 
Cu metabolism (20). Our demonstration of Cu rescue of coa6Δ yeast cells motivates further 
investigation of Cu-mediated rescue of COA6 deficiency in mammalian cells.   
 
Although Cu supplementation offers an exciting therapeutic avenue for mitochondrial patients 
with aberrant mitochondrial Cu metabolism, many important questions regarding the mechanism 
of Cu-mediated rescue and the Cu-delivery pathway remain unanswered. For example, why and 
how is Cu supplementation able to bypass the complete absence of a Cu metallochaperone? Why 
are there so many IMS proteins in the Cu delivery pathway? Despite the discovery of several 
IMS Cu-binding proteins over the last decade and a half, our understanding of the mitochondrial 
Cu delivery pathway to CcO subunits remains incomplete. In S. cerevisiae, up to ten proteins 
(Cox11, Sco1, Sco2, Cox17, Cox19, Cox23, Cmc1, Cmc2, Pet191, and Pic2) have been 
implicated so far in the Cu delivery pathway to CcO (11,14). It has been suggested that in a daisy 
chain transfer mechanism, Cu is successively transferred from its non-protein ligand in the 
mitochondrial matrix to the IMS proteins for final delivery to Cox1 and Cox2 (11) (Fig. 10A). 
However, only the last few steps that involve successive transfer of Cu from Cox17 to Cox1 and 
Cox2 via Cox11 and Sco1, respectively, are well characterized (21,22).  
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The current hypothesis in the field of mitochondrial Cu trafficking is that the proteins which 
participate in Cu delivery to CcO transfer Cu ions in a linear pathway, eventually reaching 
Cox17 (9).  Cox17 then donates Cu to Cox11 and Sco1, which successively metallate Cox1 and 
Cox2, respectively. However, a number of observations do not support this linear model of Cu 
trafficking in the IMS. For example, the growth of yeast knockouts for Cox17 and Cmc1, twin 
Cx9C Cu metallochaperones, can be rescued by exogenous Cu supplementation (9,23). This is 
unlikely in a linear pathway, and suggests the presence of parallel pathways of Cu delivery to 
CcO, a far more evolutionarily favorable model considering the essential role of CcO in 
mitochondrial energy generation.  Additionally, recent in vitro Cu transfer experiments between 
purified bacterial Sco proteins and Cox2, which contains the CuA site in eukaryotic CcO, do not 
proceed to completion (24).  This evidence suggests that the final steps of Cox2 metallation 
Figure 10. Mitochondrial Cu metabolism. (A) Schematic of the proposed mitochondrial Cu transport pathways 
to CcO subunits. Cu (blue circles) enters the mitochondrial matrix bound to an unidentified ligand (-L) partially 
through the recently identified Pic2 protein. Cu is stored in the matrix and exported to the intermembrane space 
to be delivered to CcO through a series of metallochaperones depicted in red. Only the final steps of Cu delivery 
mediated by Cox17, Cox11 and Sco1 are experimentally demonstrated. Dashed arrows indicate the hypothetical 
role of the several Cx9C containing proteins, including Coa6, in Cu transfer from a matrix Cu pool, across the 
inner mitochondrial membrane, to CcO. (B) Proposed parallel pathway of Coa6-mediated Cu delivery to the CuA 
site of CcO. 
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require additional and as-of-yet unidentified Cu metallochaperones. We predict Coa6 to be either 
a regulator or a bona fide member of the Cu-delivery pathway to CcO because of the presence of 
the highly conserved Cx9C-Cx10C motif, its localization to the IMS, and the rescue a respiratory 
growth defect in yeast coa6Δ cells by exogenous Cu supplementation.  The diminished tetrad 
formation from sporulation of double knockouts between Coa6 and proteins known to be 
involved in Cu delivery to Cox2 suggest that Coa6 participates specifically in this facet of 
mitochondrial Cu metabolism. Most notably, however, is the finding that the double knockout 
between Coa6 and Sco2 cannot be rescued by exogenous Cu supplementation.  This suggests 
that Coa6 participates in either a parallel pathway of Cu delivery to CcO, whose absence can be 
compensated for by the addition of exogenous Cu, or acts upstream of Sco2 (Fig. 10B). 
 
Much remains to be determined concerning mitochondrial Cu metabolism. The full 
characterization of the pathway by which CcO receives its Cu cofactors is an important 
objective, as it will not only fundamentally enhance the field of mitochondrial biology, but may 
also yield information about which mitochondrial disease patients may benefit from treatment by 
Cu supplementation.  Elucidation of the role of Coa6 in mitochondrial energy generation is the 
proof-of-principle of our combined computational, genetic, and biochemical strategy to identify 
novel MRC biogenesis factors, and will bring the field of mitochondrial medicine one step closer 
to understanding the full complement of genes required for building the mitochondrial energy 
generating machinery. 
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